Results 91 to 100 of about 36,016 (212)

Real‐world use of second‐generation integrase strand transfer inhibitors (INSTI) as switch therapy in the prospective ANRS‐CO3‐AquiVIH‐NA cohort

HIV Medicine, Volume 27, Issue 6, Page 965-978, June 2026.
Abstract Objectives To characterize real‐world treatment switching in France to bictegravir (BIC or B) or dolutegravir (DTG)‐based regimens with a focus on treatment persistence, effectiveness (HIV‐1 RNA ≤50 copies/ml) and particular attention to the prevalence and incidence of comorbidities. Methods People living with HIV from the prospective ANRS‐CO3‐
O. Leleux, A. Peyrouny‐Mazeau, A. Perrier, M. Hessamfar, G. Le Moal, D. Neau, L. Alleman, C. Cazanave, E. Lazaro, P. Duffau, A. Riché, Y. Gérard, G. Barrière, S. Reigadas, M.‐A. Vandenhende, F. Bonnet   +15 more
wiley   +1 more source

Probing rate of YMDD motif mutant in lamivudine treatment of Iranian patients with chronic hepatitis B virus infection

Asian Journal of Transfusion Science, 2011
Background: Lamivudine is an analog nucleoside used for the treatment of chronic hepatitis B virus (CHV) infection. Studies showed that prolonged therapy could induce lamivudine resistance hepatitis B virus (HBV) variants (YMDD motif). In this study, the
Ghandehari Freshte, Pourazar Abasali, Zadeh Mehrnaz, Tajedin Nahid   +3 more
doaj  

Prevalence of Sleep Apnea and Sleepiness in Adults With and Without HIV in Mwanza, Tanzania: Baseline Results From an Ongoing Cohort Study

Journal of Sleep Research, Volume 35, Issue 3, June 2026.
ABSTRACT We conducted a cross‐sectional analysis of the baseline survey of participants aged > 30 years enrolled in the Mwanza HIV&CVD Cohort in Tanzania. Our primary objective was to examine the association between HIV status and sleep apnea (SA).
Godfrey A. Kisigo, Benson Issarow, Salama Fadhil, Grace Ruselu, Ponsiano Fabian, Ayubu Garbindi, Robert N. Peck, Kathy Baisley, Saidi Kapiga, Ana C. Krieger   +9 more
wiley   +1 more source

Population Pharmacokinetic Model for Adherence Evaluation Using Lamivudine Concentration Monitoring

, 2012
Background: Interpretation of antiretroviral drug concentration measurements could be aided by information about adherence to recent doses. We developed a population pharmacokinetic model of lamivudine in young children to propose reference lamivudine ...
Karlsson, Mats O.,, Denti, Paolo, van der Walt, Jan-Stefan, Zhang, Chao, McIlleron, Helen, Ren, Yuan, Smith, Peter   +6 more
core   +1 more source

Acute pancreatitis associated with lamivudine therapy for chronic B hepatitis [PDF]

, 2008
Hyperamylasemia is a common complication during lamivudine use. We report a case of a pancreatitis following lamivudine therapy. A careful monitoring of amylase levels during treatment with lamivudine is discussed, mainly in the first weeks, considering ...
BOULOS, Maria Ivete Castro, GUASTINI, Cristina Maria de Fátima, TUON, Felipe Francisco   +2 more
core   +1 more source

Hepatitis B Surface Antigen Loss and Improved Clinical Outcomes in US Individuals With Chronic Hepatitis B Virus Infection

Journal of Viral Hepatitis, Volume 33, Issue 6, June 2026.
ABSTRACT Hepatitis B surface antigen (HBsAg) loss is associated with improved clinical outcomes in patients with chronic hepatitis B virus (HBV) infection based on studies predominantly in Asian populations. We assessed real‐world associations between HBsAg loss and long‐term clinical outcomes in a diverse US population with chronic HBV infection. This
Myriam Drysdale, Rose Chang, Shuang Wang, Anna Coutinho, Vera Gielen, Theo Man, Rui Song, Mei Sheng Duh, Mandana Khalili, Dickens Theodore   +9 more
wiley   +1 more source

Mutations in HIV-1 reverse transcriptase during therapy with abacavir, lamivudine and zidovudine in HIV-1-infected adults with no prior antiretroviral therapy

, 2002
Objective: To evaluate HIV-1 reverse transcriptase (RT) drug resistance in patients receiving abacavir, lamivudine and zidovudine therapy. Methods: In a randomized, double-blind study, 173 antiretroviral treatment-naive HIV-1-infected adults received ...
Pulido Ortega, Federico, Lafon, Steve, Ait-Khaled, Mounir, Rubio García, Rafael   +3 more
core   +1 more source

Dolutegravir And Lamivudine Combination For The Treatment Of HIV-1 Infection

HIV/AIDS: Research and Palliative Care, 2019
Francis J Zamora,1,2 Ellen Dowers,2 Faiza Yasin,3 Onyema Ogbuagu3 1Department of Pharmacy Services, Broward Health Medical Center, Fort Lauderdale, FL, USA; 2Department of Pharmacy Services, Yale-New Haven Hospital, New Haven, CT, USA; 3Section of ...
Zamora FJ, Dowers E, Yasin F, Ogbuagu O
doaj  

Lamivudine plasma levels in chronic hepatitis B patients [PDF]

, 2003
Lamivudine has recently been registered for the treatment of chronic hepatitis B patients. The main therapeutic outcome in the studies on which the registration was based was a drop of HBV DNA below 10(7) genome equivalents/ml, the ...
Dijk, L.J. (Laurens) van, Geerlings, C.J., van Dijk, L, de Man, Rob, Niesters, H.G.M. (Bert), Niesters, HGM, Wolters, LMM (Leonieke), Wolters, L.M.M. (Leonieke), Vulto, A.G. (Arnold), Vulto, Arnold; id_orcid, Man, R.A. (Robert) de, Geerlings, CJC   +11 more
core   +2 more sources

Clinical characteristics of 89 HIV-positive patients coinfected with lamivudine-resistant or lamivudine-susceptible hepatitis B virus

, 2016
Clinical characteristics of 89 HIV-positive patients coinfected with lamivudine-resistant or lamivudine-susceptible hepatitis B ...
Sui-Yuan Chang (39460), Hsin-Yun Sun (61134), Kuan-Yeh Lee (523493), Yi-Ching Su (734372), Shan-Chwen Chang (91714), Wang-Huei Sheng (103262), Wen-Chun Liu (61140), Yu-Shan Huang (847180), Chien-Ching Hung (61132), Yu-Chung Chuang (236282)   +9 more
core   +1 more source